2007
DOI: 10.1139/w07-095
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal susceptibility of bloodstream yeasts isolated at a public children’s hospital in Brazil: comparison of the Etest® and the AFST–EUCAST microdilution method

Abstract: This study compared the minimum inhibitory concentration (MIC) results from the proposed standard methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (AFST-EUCAST) with the commercial system Etest(R) in the evaluation of susceptibility to flucytosine, fluconazole, itraconazole, voriconazole, and amphotericin B of 136 Candida spp. isolated from the blood of hospitalized children. The results presented a greater agreement among Etest(R) MIC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0
13

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(26 citation statements)
references
References 20 publications
1
12
0
13
Order By: Relevance
“…In pediatric or neonatal units, C. parapsilosis has been marked as the second most common agent in patients with candidemia, a fact that is linked to the exogenous contamination because of the patients' manipulation by the hospital staff, the patients' exposure to invasive procedures in the ICU, prematurity, immunosuppression, and long-course antibiotic therapy 34,35,[39][40][41] . Results from many other works have evidenced C. tropicalis or C. parapsilosis as the main Candida non-albicans agent involved in the different types of candidemia around us 38,[42][43][44][45][46][47] , which is different from what has been observed in Europe and North America, where C. glabrata has been detected as the second most recurrent pathogen after C. albicans 43,44,[47][48][49] . This species was not isolated in our research.…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…In pediatric or neonatal units, C. parapsilosis has been marked as the second most common agent in patients with candidemia, a fact that is linked to the exogenous contamination because of the patients' manipulation by the hospital staff, the patients' exposure to invasive procedures in the ICU, prematurity, immunosuppression, and long-course antibiotic therapy 34,35,[39][40][41] . Results from many other works have evidenced C. tropicalis or C. parapsilosis as the main Candida non-albicans agent involved in the different types of candidemia around us 38,[42][43][44][45][46][47] , which is different from what has been observed in Europe and North America, where C. glabrata has been detected as the second most recurrent pathogen after C. albicans 43,44,[47][48][49] . This species was not isolated in our research.…”
Section: Discussionmentioning
confidence: 87%
“…Fifty percent to 60% of the patients who present this species are expected to develop systemic infections 38 . Other studies point to C. parapsilosis as the most prevalent species among the Candida non-albicans [1][2][3][4]18,24,34,35,39 .…”
Section: Discussionmentioning
confidence: 99%
“…Outro fator que tem dado origem a casos alarmantes de resistência aos antifúngicos, entre as espécies de Candida, é a administração por períodos prolongados do fármaco em casos de infecção e o uso profilático dos antifúngicos tais como a anfotericina B e os azóis menos tóxicos (Pfaller et al, 1995;Matsumoto et al, 2007 inkin, T. asteroides e T. cutaneum Bentubo et al, 2013).…”
Section: Como Principais Métodos De Identificação Espécie-específica unclassified
“…É uma excelente técnica de determinação da sensibilidade aos antifúngicos "in vitro", simples, de fácil execução, com resultados rápidos, não necessitando de equipamentos de custos elevados ou especializados (Pfaller et al, 1995;Silva et al, 2002;Matsumoto et al, 2007;Navarini, 2007).…”
Section: Método Comercial "Etest®"unclassified
See 1 more Smart Citation